Users' guides to the medical literature: XIV. How to decide on the applicability of clinical trial results to your patient

JAMA

Volumn 279, Issue 7, 1998, Pages 545-549

  Dans, Antonio L ^b   Dans, Leonila F ^b   Guyatt, Gordon H ^a,d   Richardson, Scott ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC THERAPY; MEDICAL LITERATURE; MEDICAL RESEARCH; PHILIPPINES; PRIORITY JOURNAL; REVIEW;

EID: 0032542553     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.7.545     Document Type: Review

References (33)

1. Midgette AS, O'Connor GT, Baron JA, Bell J. Effect of intravenous steptokinase on early morality in patients with suspected acute myocardial infarction: a meta-analysis by anatomic location of infarction. Ann Intern Med. 1990;113:961-968.
2. ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349-360.
3. Oxman AD, Cook DJ, Guyatt GH, for the Evidence-Based Medicine Working Group. Users' guides to the medical literature, VI: how to use an overview. JAMA. 1994;272:1367-1371.
4. Guyatt GH, Sackett DL, Cook DJ, for the Evidence-Based Medicine Working Group. Users' guides to the medical literature, II: how to use an article about therapy or prevention, A: are the results of the study valid? JAMA. 1993;270:2598-2601.
5. Guyatt GH, Sackett DL, Cook DJ, for the Evidence-Based Medicine Working Group. Users' guides to the medical literature, II: how to use an article about therapy or prevention, B: what were the results and will they help me in caring for my patients? JAMA. 1994;271:59-63.
6. Friedman LM, Furberg CD, DeMets DL. Fundamentals of Clinical Trials. 2nd ed. Little, Mass: PSG Publishing Co Inc; 1985.
7. Falkner B, Kushner H. Effect of chronic sodium loading on cardiovascular response in young blacks and whites. Hypertension. 1990;15:36.
8. Wilson TW. History of salt supplies in West Africa and blood pressure today. Lancet. 1986;1:784.
9. World Health Organization. World malaria situation in 1992, part 1. Wkly Epidemiol Rec. 1994;69: 309-314.
10. Davis CE. Generalizing from clinical trials. Control Clin Trials. 1994;15:11-14.
11. Canlas MM, Dominguez AE, Abarquez RF. Ten-year review of the clinicopathologic findings of coronary artery disease at the University of the Philippines, Philippine General Hospital (1969-1978). Phil J Int Med. 1980;18:65-74.
12. Roberts WC, Potkin BN, Solus DE, et al. Mode of death, frequency of healed and acute myocardial infarction, number of major epicardial coronary arteries severely narrowed by atherosclerotic plague, and heart weight in fatal atherosclerotic coronary artery disease: analysis of 889 patients studied at necropsy. J Am Coll Cardiol. 1990;15:196-202.
13. Balgos AA, Lopez MB, delos Santos E, et al. The significance of risk factors in myocardial infarction - a 2-year retrospective study at the University of the Philippines, Philippine General Hospital. Philippine J Cardiol. 1984;12:104-108.
14. Farmer JA, Gotto AM. Dyslipidemia and other risk factors for coronary artery disease. In: Braunwald E, ed. Heart Disease - A Textbook of Cardiovascular Medicine. 5th ed. Philadelphia, Pa: WB Saunders Co; 1997:1126-1160.
15. Horai Y, Ishizaki T. Pharmacogenetics and its clinical implication: N-acetylation polymorphism. Ration Drug Ther. 1987;21:1-7.
16. Goodman GA, Rall TW, Nies AS, Taylor P. Principles of therapeutics. In: The Pharmacologic Basis of Therapeutics. 8th ed. New York, NY: Pergamon Press Inc; 1991:71-73.
17. Ward J, Brenneman G, Letson GW, Heyward WL. Limited efficacy of a Haemophilus type b conjugate vaccine in Alaska Native infants: the Alaska H influenzae Vaccine Study Group. N Engl J Med. 1990;323:1415-1416.
18. Martino E, Safran M, Aghini-Lombardi F, et al. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med. 1984;101:28-34.
19. Dela Paz AG, Pineda NE, Justiniani RP, et al. Thrombolysis in acute myocardial infarction. Philippine J Cardiol. 1988;17:185-188.
20. Bulatao J. Split-Level Christianity. Manila, Philippines: University of Sto Tomas Press; 1966.
21. Raja SN, Williams S, McGee R. Multidimensional health locus of control beliefs and psychological health for a sample of mothers. Soc Sci Med. 1994;39:213-220.
22. Barnett HJM, Eliasziw M, Meldrum HE, Taylor DW. Do the facts and figures warrant a 10-fold increase in the performance of carotid endarterectomy on asymptomatic patients? Neurology. 1996; 46:603-608.
23. Gersh BJ, Opie LH. Antithrombotic agents: platelet inhibitors, anticoagulants and fibrinolytics. In: Opie LH, ed. Drugs for the Heart. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1991.
24. Glasziou PP, Irwig LM. An evidence based approach to individualising treatment. BMJ. 1995;311: 1356-1358.
25. Sazawal S, Black RE. Meta-analysis of intervention trials on case management of pneumonia in community settings. Lancet. 1992;340:528-533.
26. Sharp SJ, Thompson SG, Altman DG. The relation between treatment benefit and underlying risk in meta-analysis. BMJ. 1996;313:735-738.
27. Rothwell PM. Can overall results of clinical trials be applied to all patients? Lancet. 1995;345:1616-1619.
28. Bailey KR. Generalizing the results of randomized clinical trials. Control Clin Trials. 1994;15:15-23.
29. Oxman AD, Guyatt GH. A consumer's guide to subgroup analysis. Ann Intern Med. 1992;116;78-84.
30. Yusuf S, Wittes J, Probstfield J, Tyroler HA. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA. 1991;266:93-98.
31. Keys A. Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease. Cambridge, Mass: Harvard University Press; 1980.
32. World Health Organization Monitoring of Cardiovascular Disease and Their Determiants (MONICA). WHO MONICA Project: assessing CHD mortality and morbidity. Int J Epidemiol. 1989;18(suppl 3, pt 1):S38-S45.
33. Guyatt GH, Sackett DL, Sinclair JC, Hayward R, et al, for the Evidence-Based Medicine Working Group. Users' guides to the medical literature, IX: a method for grading health care recommendations. JAMA. 1995;274:1800-1804.